Abstract
Congenital amegakaryocytic thrombocytopenia (CAMT) is a rare inherited disorder that presents with thrombocytopenia in infancy and evolves into bone marrow failure over time. Allogeneic hematopoietic stem cell transplant remains the only curative treatment option. We report our experience with identical twin sisters diagnosed with CAMT and treated successfully with matched unrelated donor bone marrow transplants. Before the transplant, 1 twin developed pancytopenia, whereas the other had a relatively benign clinical course. Choice of conditioning regimens was based on their pretransplant bone marrow cellularity and presence or absence of panyhypoplasia. Both twins tolerated the procedure well with no significant complications.
Original language | English (US) |
---|---|
Pages (from-to) | 304-306 |
Number of pages | 3 |
Journal | Journal of Pediatric Hematology/Oncology |
Volume | 37 |
Issue number | 4 |
DOIs | |
State | Published - Dec 1 2015 |
Keywords
- bone marrow failure
- congenital amegakaryocytic thrombocytopenia
- hematopoietic stem cell transplant
- matched unrelated donor
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology